EPI vs XBI
WisdomTree India Earnings Fund vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.84% for EPI.
- • XBI pays a higher dividend yield (0.35%).
Side-by-side metrics
| Metric | EPI | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.84% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $1.78B | $10.92B |
YTD return | -4.97% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.67 | 1.01 |
P/E ratio | 18.92 | — |
Last price | $44.26 | $156.41 |
Inception | — | — |
Issuer | WisdomTree | State Street |
EPI top holdings
| RELIANCE.NS | Reliance Industries Ltd | 0.69% |
| HINDPETRO.NS | Hindustan Petroleum Corp Ltd | 0.57% |
| ICICIBANK.NS | ICICI Bank Ltd | 0.55% |
| POWERGRID.BO | Power Grid Corp Of India Ltd | 0.52% |
| NTPC.BO | NTPC Ltd | 0.51% |
| HDFCBANK.NS | HDFC Bank Ltd | 0.51% |
| LT.NS | Larsen & Toubro Ltd | 0.46% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About EPI
EPI (WisdomTree India Earnings Fund) is Indian companies weighted by earnings. Managed by WisdomTree, the fund carries $1.8B in assets under management, an expense ratio of 0.84%. Its largest holding is Reliance Industries Ltd (RELIANCE.NS), which represents 0.7% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.